Masaru Harada
5PUBLICATIONS
25CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (5)
Sort by Publication Date:
|Aug 21, 2025
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study.Takeshi Hatanaka, Shigeo Shimose, Takanori Ito
|May 28, 2025
A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination therapy in hepatocellular carcinoma.Tetsu Tomonari, Shigeo Shimose, Issei Saeki
|Apr 26, 2025
Usefulness of the Early Increase of Peripheral Blood Lymphocyte Count in Predicting Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma Treated with Durvalumab Plus Tremelimumab.Yuichi Honma, Michihiko Shibata, Masatoshi Ikemi
|Jun 05, 2019
Idiopathic copper toxicosis: is abnormal copper metabolism a primary cause of this disease?Masaru Harada, Yuichi Honma, Tomoharu Yoshizumi
Pageof 1
Frequent Collaborators
4 joint publications
Yuichi Honma
2 joint publications
Shigeo Shimose
2 joint publications
Issei Saeki
2 joint publications
Takeshi Hatanaka
2 joint publications
Satoru Kakizaki
2 joint publications
Taro Takami
2 joint publications
Motoyuki Otsuka
2 joint publications
Yasushi Sato
2 joint publications
Sohji Nishina
2 joint publications
Hisamitsu Miyaaki